20065 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
FORMULATIONS AND METHODS FOR MHC-I RESTRICTED EPITOPE IMMUNIZATION
#302PEPTIDE CONJUGATED PARTICLES
#303METHOD FOR PRODUCING LIPOSOMES ENTRAPPING CYCLOSPORINE A
#304PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#305Coronavirus vaccine
#306BORONATED NANOSCALE SUBSTRATE AND USES THEREOF
#307USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME
#308TREATMENT OF PAIN IN PEDIATRIC PATIENTS BY ADMINISTRATION OF SUSTAINED-RELEASE LIPOSOMAL ANESTHETIC COMPOSITIONS
#309COMPOSITION COMPRISING A COMBINATION GROWTH FACTORS FOR PREVENTING RADIATION-INDUCED DAMAGE IN CANCER PATIENTS TREATED WITH RADIOTHERAPY
#310COMPOSITIONS AND METHODS FOR DELIVERY OF ANTICANCER AGENTS WITH IMPROVED THERAPEUTIC INDEX
#311USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS FOR TREATING TP53-MUTATED ACUTE MYELOID LEUKEMIA
#312COMPOSITIONS FOR FACILITATING MEMBRANE FUSION AND USES THEREOF
#313Synthetic platelets
#314Alpha polyglutamated pralatrexate and uses thereof
#315Combination of BI853520 with chemotherapeutic drugs
#316USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE
#317NONCOMPETITIVE RECEPTOR-TARGETED VACCINE DELIVERY TO PLASMACYTOID DENDRITIC CELLS
#318NOVEL CRISPR ENZYMES AND SYSTEMS
#319LIPID NANOPARTICLES
#320PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA
#321MRNA THERAPY FOR POMPE DISEASE
#322Mesothelioma Gene Therapy
#323MICROFLUIDIC DEVICE FOR ISOLATING COMPONENTS OF BODILY FLUIDS
#324Compositions and methods for nanoparticle lyophile forms
#325INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
#326FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION
#327LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE
#328TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#329Nucleic Acid-Based Therapy of Muscular Dystrophies
#330Remote loading of sparingly water-soluble drugs into lipid vesicles
#331METHODS FOR PRODUCTION OF MSC-DERIVED EXOSOMES
#332HYBRID BIOLOGICAL MEMBRANES, METHODS OF MAKING AND USES THEREOF
#333POLYGLUTAMATED ANTIFOLATES AND USES THEREOF
#334Method of Safe Administration of Phosphorylated TAU Peptide Vaccine
#335COMPOSITIONS AND METHODS FOR TARGETING CORONAVIRUS USING LIPID VESICLES INCLUDING EXOSOMES
#336LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#337METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IMMUNE RESPONSES
#338TES-BASED CATIONIC LIPIDS
#339FUSOGENIC LIPID NANOPARTICLES FOR TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN FUSOGENIC LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE
#340Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#341LIPOSOME COMPRISING RAPAMYCIN OR A DERIVATIVE THEREOF AND USE THEREOF IN THERAPY
#342LIPID NANOPARTICLES
#343SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS
#344Liposomes Containing Phosphorylated Tau Peptides for Inducing Sustained Immune Responses
#345RESPIRATORY VIRUS IMMUNIZING COMPOSITIONS
#346ORGANIC SOL-GEL NANO-COMPOSITION FROM PANAX NOTOGINSENG, RUTIN, GINKGO BILOBA EFFECTIVE IN ENHANCING CEREBRAL AND CARDIOVASCULAR PROTECTION AND METHOD OF PRODUCING THEREOF
#347SYSTEMS FOR TREATING PULMONARY INFECTIONS
#348Lipid nanoparticle compositions and methods for mRNA delivery
#3492-DEOXY-D-GLUCOSE FOR PREVENTION AND TREATMENT OF A VIRAL DISEASE, IN PARTICULAR OF COVID-19
#350NANO LIPID CARRIER SYSTEM FOR IMPROVING PERMEATION OF ACTIVE INGREDIENTS
#351CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES
#352COMPOSITION FOR PROMOTING DRUG RELEASE OF DRUG-DELIVERY LIPOSOMES
#353LIPIDIC COMPOUNDS COMPRISING AT LEAST ONE TERMINAL RADICAL OF FORMULA -NH-CX-A OR -NH-CX-NH-A, COMPOSITIONS CONTAINING THEM AND USES THEREOF
#354LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#355Amphiphilic material and application thereof in preparation for liposome
#356Lipid nanoparticle compositions and methods for MRNA delivery
#357Lipid nanoparticle compositions and methods for MRNA delivery
#358METHODS OF PREPARING LIPID NANOPARTICLES
#359LAYER-BY-LAYER COATED NANOLIPOSOME FOR ORAL DELIVERY OF INSULIN
#360DIAGNOSTIC METHODS FOR CANCER USING AXL DECOY RECEPTORS
#361METHODS OF PREPARING LIPID NANOPARTICLES
#362LEVERAGING LIPID-PROTEIN INTERACTIONS TO ENGINEER SPATIAL ORGANIZATION IN CELL-FREE SYSTEMS
#363PEPTIDE-NANOPARTICLE CONJUGATES
#364TARGETED DELIVERY OF EXTRACELLULAR VESICLES
#365Heterologous Administration of Tau Vaccines
#366Limit size lipid nanoparticles and related methods
#367METHOD OF PREPARING LIPID VESICLES
#368Bisphosphonate-Modified Liposomes Containing Nanoparticles
#369NON-INTUITIVE COMBINATION OF DRUG DELIVERY CARRIERS OF THE SAME DRUG FOR SYNERGISTIC GROWTH DELAY OF SOLID TUMORS
#370GSK3 INHIBITOR-LOADED NANO FORMULATIONS AS A CANCER IMMUNOTHERAPEUTIC
#371PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES
#372ENCAPSULATION OF MICROBUBBLES WITHIN THE AQUEOUS CORE OF MICROCAPSULES
#373Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis
#374PHENYLALANINE HYDROXYLASE VARIANTS AND USES THEREOF
#375CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#376SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 AGONIST AND LIPOSOMAL FORMULATIONS THEREOF
#377CIRCULAR RNA COMPOSITIONS AND METHODS
#378LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION
#379FUSOGENIC LIPID NANOPARTICLES AND METHODS FOR THE MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE, CONDITION, OR DISORDER ASSOCIATED WITH A TARGET CELL
#380EXOSOME COMPRISING PHOTOCLEAVABLE PROTEIN, AND USE THEREOF
#381Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
#382RECOMBINANT POLYPEPTIDES FOR MEMBRANE FUSION AND USES THEREOF
#383Ribonucleic acids with 4′-thio-modified nucleotides and related methods
#384Treatment of primary ciliary dyskinesia with synthetic messenger RNA
#385IMPROVED COMPOSITIONS FOR CFTR MRNA THERAPY
#386Liposomes Useful for Drug Delivery
#387Hybridosomes, compositions comprising the same, processes for their production and uses thereof
#388LIPID-BASED NANOPARTICLES WITH ENHANCED STABILITY
#389COMPOSITIONS COMPRISING ANTI-VEGF AND NANOPARTICLES AND METHODS OF USING THE SAME FOR THE TREATMENT OF ABNORMAL OR EXCESSIVE ANGIOGENESIS
#390COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#391TREATING MICROVASCULAR DYSFUNCTION
#392VESICLE COMPOSITIONS FOR ORAL DELIVERY
#393CATIONIC LIPIDS FOR LIPID NANOPARTICLE DELIVERY OF THERAPEUTICS TO HEPATIC STELLATE CELLS
#394COMPOSITION AND METHODS FOR TREATMENT OF METHYLMALONIC ACIDEMIA
#395A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE
#396FORMULATIONS
#397DOSAGE FORMS FOR IMPROVING ORGAN TRANSPLANTATION, GRAFT VERSUS HOST DISEASE AND STEM CELLS TRANSPLANTS
#398HYBRID htiRNA / NANOPARTICLE COMPLEX AND USE THEREOF FOR TREATING A DISEASE OF THE DIGESTIVE SYSTEM
#399TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS
#400Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#401CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGO
#402D glutamate polyglutamated antifolates and uses thereof
#403METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
#404IPA-3-loaded liposomes and methods of use thereof
#405Stabilizing Camptothecin Pharmaceutical Compositions
#406NOVEL CRISPR ENZYMES AND SYSTEMS
#407EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER
#408In Vivo Targeting of Extracellular Vesicles
#409Lipid particle, composition comprising lipid particle, and method for delivering activators to cell
#410FUSOGENIC LIPOSOME-COATED POROUS SILICON NANOPARTICLES
#411Methods For Treating Pancreatic Cancer Using Combination Therapies
#412LACTOFERRIN FOR ORAL USE WITH ANTIVIRAL ACTION
#413COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGS
#414Coronavirus vaccine
#415Combination therapy for cancer treatment
#416CORONAVIRUS VACCINE
#417SUBCUTANEOUS DELIVERY OF MESSENGER RNA
#418Methods for Treating Metastatic Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan and Oxaliplatin
#419DRY LIPOSOME ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF
#420LIPOSOMAL FORMULATIONS OF BCL INHIBITORS
#421GAS-FILLED MICROVESICLES FOR THERAPEUTIC USE
#422DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF
#423RECTAL DELIVERY OF MESSENGER RNA
#424NUCLEIC ACID LOADED RED BLOOD CELL EXTRACELLULAR VESICLES
#425Multisomes: encapsulated droplet networks
#426FUSOSOME COMPOSITIONS FOR T CELL DELIVERY
#427MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY
#428NAD(H) NANOPARTICLES AND METHODS OF USE
#429TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS
#430STERICALLY STABILIZED CARRIER FOR AEROSOL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL
#431EXOSOME SYSTEMS, PRODUCTS AND METHODS
#432PROCESSES OF PREPARING POLYGLUTAMATED ANTIFOLATES AND USES OF THEIR COMPOSITIONS
#433Varicella zoster virus (VZV) vaccine
#434COMPOSITIONS AND METHODS FOR USE IN TYPE 1 DIABETES
#435Composition of extracellular vesicles (EVS) and medical uses thereof
#436CAROTENOID COMPOSITIONS AND USES THEREOF
#437METHOD FOR MEASURING NUCLEIC ACID CONTENT IN LIPID NANOPARTICLES USING ULTRAVIOLET SPECTROMETRY
#438CERAMIDE ANALOG SACLAC MODULATES SPHINGOLIPID LEVELS AND MCL-1 SPLICING TO INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA
#439Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions
#440COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
#441Lipid nanoparticle compositions and methods for mRNA delivery
#442Polyglutamated antifolates and uses thereof
#443LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#444LOCALIZED RELEASE OF SYSTEMICALLY CIRCULATING THERAPEUTIC SUBSTANCES
#445COMPOSITIONS AND METHODS FOR PULMONARY SURFACTANT-BIOMIMETIC NANOPARTICLES
#446Freeze-dried product and gas-filled microvesicles suspension
#447LIPOSOMAL TROPONOID COMPOUND FORMULATIONS
#448TARGETED NANOPARTICLES AND THEIR USES RELATED TO FUNGAL INFECTIONS
#449STERICALLY STABILIZED CARRIER FOR SUBCUTANEOUS, SUBLINGUAL AND ORAL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING A MAMMAL
#450PROCESS FOR FORMULATING AN ANIONIC AGENT
#451CORE/SHELL STRUCTURE PLATFORM FOR IMMUNOTHERAPY
#452Vancomycin Liposome Compositions and Methods
#453LIPID VESICLE-MEDIATED DELIVERY TO CELLS
#454EXOSOME MIMICKING NANOVESICLES MAKING AND BIOLOGICAL USE
#455Stable Liquid Lipid Nanoparticle Formulations
#456TUNABLE LEUKOCYTE-BASED BIOMIMETIC NANOPARTICLES AND METHODS OF USE
#457Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#458RNA constructs and uses thereof
#459Film Formulation Comprising Carriers
#460NANOMATERIALS CONTAINING CONSTRAINED LIPIDS AND USES THEREOF
#461MODIFIED PLANT MESSENGER PACKS AND USES THEREOF
#462Treatment of hip pain with sustained-release liposomal anesthetic compositions
#463Targeted contrast agents for MRI of alpha-synuclein deposition
#464COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS
#465POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS FOR THE TREATMENT OF PROPIONIC ACIDEMIA
#466LIPOSOMAL DOXORUBICIN FORMULATION, METHOD FOR PRODUCING A LIPOSOMAL DOXORUBICIN FORMULATION AND USE OF A LIPOSOMAL DOXORUBICIN FORMULATION AS A MEDICAMENT
#467MULTICELLULAR TARGETING LIPOSOME
#468TROPICAL DISEASE VACCINES
#469Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
#470IN VIVO TARGETING OF CELLS WITH LIGAND-CONJUGATED PARTICLES
#471RNA constructs and uses thereof
#472Cytotoxic particles for targeting P2X7 receptor
#473ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASE
#474COMBINATION THERAPY WITH CD13-TARGETED CHIMERIC PROTEINS OR CHIMERIC PROTEIN COMPLEXES
#475METHOD FOR PRODUCTION OF LIPOSOMES
#476Solute carrier family 46 member 3 (SLC46A3) as marker for lipid-based nanoparticle cancer therapy and diagnostics
#477PRODUCTION AND USE OF EXTRACELLULAR VESICLE-CONTAINED ENAMPT
#478ENCAPSULATION OF MESSENGER RNA
#479EXOSOME SYSTEMS, PRODUCTS AND METHODS
#480Treatment of hip pain with sustained-release liposomal anesthetic compositions
#481IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES
#482Treatment of hip pain with sustained-release liposomal anesthetic compositions
#483Treatment of primary ciliary dyskinesia with synthetic messenger RNA
#484Gas-filled microvesicles
#485INHALABLE SUSTAINED RELEASE COMPOSITION OF BRONCHODILATOR FOR USE IN TREATING PULMONARY DISEASE
#486SYNTHETIC NANOSTRUCTURES INCLUDING NUCLEIC ACIDS AND/OR OTHER ENTITIES
#487Freeze-dried product and gas-filled microvesicles suspension
#488Cleavable lipids
#489CELL PENETRATING PEPTIDE (CPP)-MEDIATED EV LOADING
#490NUCLEIC ACID VACCINES
#491FUSOGENIC PARTICLES AND RELATED METHODS FOR DELIVERING THERAPEUTIC AGENTS TO CELLS
#492MRNA BASED ENZYME REPLACEMENT THERAPY COMBINED WITH A PHARMACOLOGICAL CHAPERONE FOR THE TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#493PEPTIDE DISPLAY TO ANTIGEN PRESENTING CELLS USING LIPID VEHICLE
#494Engineered nono-lyposomes for a targeted therapy of atherosclerosis and preparation process thereof
#495LIPID NANOPARTICLES
#496COMPOSITIONS FOR DELIVERY OF CODON-OPTIMIZED MRNA
#497Pegylated liposomes and methods of use
#498BROAD-BASED THERAPEUTIC FOR INACTIVATING COVID-19 AND OTHER VIRAL PATHOGENS USING CHEMILUMINESCENCE-ACTIVATED COMPOUNDS ENCAPSULATED IN NANOPARTICLES
#499CONCATEMERIC PEPTIDE EPITOPE RNAS
#500Liposomes and uses thereof
#501MAMC-MEDIATED BIOMIMETIC NANOPARTICLES
#502TELOMERASE-CONTAINING EXOSOMES FOR TREATMENT OF DISEASES ASSOCIATED WITH AGING AND AGE-RELATED ORGAN DYSFUNCTION
#503Polycomb-associated Non-Coding RNAs
#504TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT
#505LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#506LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#507LIVER SPECIFIC DELIVERY OF MESSENGER RNA
#508Lipid nanoparticle compositions and methods for mRNA delivery
#509LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#510Lipid nanoparticle compositions and methods for MRNA delivery
#511PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#512LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL
#513Lipid nanoparticle compositions and methods for mRNA delivery
#514COMPOSITION, METHOD AND USE THEREOF
#515Method for Producing an Exosome Containing Agent for Metastasis Suppression
#516EXTRACELLULAR VESICLE COMPRISING A FUSION PROTEIN HAVING FC BINDING CAPACITY
#517Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
#518UNIDIRECTIONAL PRESENTATION OF MEMBRANE PROTEINS IN NANOPARTICLE-SUPPORTED LIPOSOMES
#519Alpha and gamma-D polyglutamated pemetrexed antifolates and uses thereof
#520Alpha polyglutamated pemetrexed and uses thereof
#521Polyglutamated pemetrexed and uses thereof
#522Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors
#523TAILORED LIPOSOMES FOR THE TREATMENT OF BACTERIAL INFECTIONS
#524COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE
#525Compositions and methods for organ specific delivery of nucleic acids
#526Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
#527DELIVERY OF AGENTS TO INFLAMED TISSUES USING FOLATE-TARGETED LIPOSOMES
#528STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS
#529Lipid nanoparticle compositions and methods for mRNA delivery
#530Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same
#531Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same
#532POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF
#533NANOCARRIER SYSTEMS FOR IMAGING AND DELIVERY OF ACTIVE AGENTS
#534POLYNUCLEOTIDE ENCAPSULATION AND PRESERVATION USING SELF-ASSEMBLING MEMBRANES
#535IRINOTECAN LIPOSOME PREPARATION, AND PREPARATION AND APPLICATION THEREOF
#536Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
#537VESICLES
#538NANOALUM PARTICLES CONTAINING A PEGYLATED LIPID SIZING AGENT
#539Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof
#540MRNA therapy for pompe disease
#541Target-specific extracellular vesicles
#542Thermosensitive hydrogel for cancer therapeutics and methods of preparation thereof
#543NOVEL PNEUMOCOCCAL VACCINE FORMULATIONS
#544NOVEL RECOMBINANT EXOSOME AND USE THEREOF
#545LIPOSOMAL COMPOSITION CONTAINING MILD ACIDIC ACTIVE AGENT
#546Dosages and methods for delivering lipid formulated nucleic acid molecules
#547Compositions of Phosphorylated Tau Peptides and Uses Thereof
#548Autoimmune disease treatment with chemokine-loaded alginate microparticles
#549A Continuous Processing System And Methods For Internal And External Modifications To Nanoparticles
#550PUMPLESS ENCAPSULATION OF MESSENGER RNA
#551Sustained-release pharmaceutical compositions comprising a therapeutic agent for treating dementia and uses thereof
#552SYSTEMS FOR TREATING PULMONARY INFECTIONS
#553Discoidal nano universal platform for efficient delivery of PNAs
#554LIPID PRODRUGS FOR USE IN DRUG DELIVERY
#555Delivery of Urea to Cells of the Macula and Retina Using Liposome Constructs
#556TARGETED LIPID PARTICLES AND COMPOSITIONS AND USES THEREOF
#557Exosomes For Delivery Of Biotherapeutics
#558ALPHA POLYGLUTAMATED TETRAHYDROFOLATES AND USES THEREOF
#559Gamma polyglutamated pralatrexate and uses thereof
#560MULTISTAGE DELIVERY OF ACTIVE AGENTS
#561Method for preparing liposomes
#562Liposomes comprising polymer-conjugated lipids and related uses
#563COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS
#564METHODS AND COMPOSITIONS FOR TREATMENT OF INTERFERON-RESISTANT TUMORS
#565CELL-DERIVED PARTICLES PRESENTING HETEROLOGOUS CD24 AND USE THEREOF IN THERAPY
#566COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS
#567LIPIDATED PSA COMPOSITIONS AND METHODS
#568Sustained-release pharmaceutical compositions comprising an antipsychotic drug and uses thereof
#569Nanoparticle complex showing improved cellular uptake through surface modification using lipid and manufacturing method therefor
#570Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)
#571Lipid nanoparticle compositions and methods for mRNA delivery
#572MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#573Aminooxylipids for the construction of self-assembling liposomal systems enabling their subsequent modification by biologically functional molecules
#574ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF
#575LIPOSOMAL ELINAFIDE FORMULATIONS AND USES THEREOF
#576COMPOSITIONS AND METHODS FOR THE TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
#577COMPOSITIONS FOR THERAPEUTICS PRESCREENING
#578CAROTENOID COMPOSITIONS AND USES THEREOF
#579Liposomal apparatus and manufacturing methods
#580Liposomal apparatus and manufacturing methods
#581IL-1 BETA TARGETING SPHERICAL NUCLEIC ACIDS
#582Lipid formulations for nucleic acid delivery
#583Liposomal compositions and uses of same
#584LIPOSOMAL APPARATUS AND MANUFACTURING METHODS
#585Platinum complexes and uses thereof
#586COMPOSITIONS AND METHODS INVOLVING TRANSFORMING EXTRACELLULAR VESICLES
#587Compositions for Drug Delivery and Methods of Use Thereof
#588CANNABINOID-CONTAINING EXTRACTS, FORMULATIONS, AND USES THEREOF FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
#589NANOPARTICLE ARSENIC-PLATINUM COMPOSITIONS
#590SHORT INTERFERING RNA TARGETING VARIANT C1858T OF GENE PTPN22
#591Peptide-conjugated nanoparticles for targeting, imaging, and treatment of prostate cancer
#592Binary lipid bilayer-containing vesicles comprising embedded cytotoxic agents and methods of making and using the same
#593VITAMIN E DERIVATIVES AND THEIR USE AS MULTI-SCALE IMAGING AGENTS
#594NANOMATERIALS
#595Stabilizing Camptothecin Pharmaceutical Compositions
#596NUCLEIC ACID VACCINES
#597NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#598Nucleic acid loaded extracellular vesicles
#599Combined pharmaceutical formulation comprising drug-containing liposome composition and platinum preparation
#600TLR7/8 AGONISTS AND LIPOSOME COMPOSITIONS